229 related articles for article (PubMed ID: 31907569)
21. Dual-time point
Parghane RV; Basu S
Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
[TBL] [Abstract][Full Text] [Related]
22. FDG PET/CT findings of solid pseudopapillary tumor of the pancreas with CT and MRI correlation.
Dong A; Wang Y; Dong H; Zhang J; Cheng C; Zuo C
Clin Nucl Med; 2013 Mar; 38(3):e118-24. PubMed ID: 23354028
[TBL] [Abstract][Full Text] [Related]
23. Clinical correlation of metabolic parameters on
Won KS; Kim DH; Sung DH; Song BI; Kim HW; Song KS; Lee SW; Cho CH
Ann Nucl Med; 2017 Apr; 31(3):211-217. PubMed ID: 28168397
[TBL] [Abstract][Full Text] [Related]
24. Clinical and prognostic value of 18F-FDG-PET/CT in restaging of pancreatic cancer.
Albano D; Familiari D; Gentile R; Scalisi S; Midiri F; Messina M; Spada M; Fornito MC; Galia M; Midiri M; Alongi P
Nucl Med Commun; 2018 Aug; 39(8):741-746. PubMed ID: 29782393
[TBL] [Abstract][Full Text] [Related]
25. (18)F-FDG-PET/CT findings in pancreatic metastasis.
Hu S; Zhang J; Zuo C; Cheng C; Liu Q; Sun G
Radiol Med; 2015 Oct; 120(10):887-98. PubMed ID: 25795439
[TBL] [Abstract][Full Text] [Related]
26. SUVmax after (18)fluoro-deoxyglucose positron emission tomography/computed tomography: A tool to define treatment strategies in pancreatic cancer.
Pergolini I; Crippa S; Salgarello M; Belfiori G; Partelli S; Ruffo G; Pucci A; Zamboni G; Falconi M
Dig Liver Dis; 2018 Jan; 50(1):84-90. PubMed ID: 29017830
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.
Im HJ; Oo S; Jung W; Jang JY; Kim SW; Cheon GJ; Kang KW; Chung JK; Kim EE; Lee DS
Medicine (Baltimore); 2016 May; 95(19):e3686. PubMed ID: 27175707
[TBL] [Abstract][Full Text] [Related]
28.
Zhang J; Jia G; Zuo C; Jia N; Wang H
BMC Cancer; 2017 Oct; 17(1):695. PubMed ID: 29061130
[TBL] [Abstract][Full Text] [Related]
29. Limited diagnostic value of Dual-Time-Point (18)F-FDG PET/CT imaging for classifying solitary pulmonary nodules in granuloma-endemic regions both at visual and quantitative analyses.
Chen S; Li X; Chen M; Yin Y; Li N; Li Y
Eur J Radiol; 2016 Oct; 85(10):1744-1749. PubMed ID: 27666611
[TBL] [Abstract][Full Text] [Related]
30. Dual-phase 18F-FDG PET/CT imaging in the characterization of pancreatic lesions: does it offer prognostic information?
Santhosh S; Mittal BR; Bhasin D; Rana SS; Bhattacharya A; Srinivasan R; Nada R; Gupta R
Nucl Med Commun; 2014 Oct; 35(10):1018-25. PubMed ID: 25023999
[TBL] [Abstract][Full Text] [Related]
31. PET/CT in brachytherapy early response evaluation of pancreatic ductal adenocarcinoma xenografts: comparison with apparent diffusion coefficient from diffusion-weighted MR imaging.
Liu Y; Liu M; Liu X; Zhou Y
Abdom Radiol (NY); 2019 Mar; 44(3):950-957. PubMed ID: 30315322
[TBL] [Abstract][Full Text] [Related]
32. Metabolic changes in breast cancer on dual-time-point
Kim HO; Kim BS; Kang SY; Bang JI; An J; Kim JH; Yoon HJ
Ann Nucl Med; 2020 Dec; 34(12):942-951. PubMed ID: 32974848
[TBL] [Abstract][Full Text] [Related]
33. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
Lin CY; Liao CW; Chu LY; Yen KY; Jeng LB; Hsu CN; Lin CL; Kao CH
Clin Nucl Med; 2017 Apr; 42(4):e183-e187. PubMed ID: 28114226
[TBL] [Abstract][Full Text] [Related]
34. Functional imaging of interstitial brachytherapy in pancreatic carcinoma xenografts using spectral CT: how does iodine concentration correlate with standardized uptake value of (18)FDG-PET-CT?
Hu S; Shi X; Chen Y; Huang W; Song Q; Lin X; Liu Y; Chen K; Wang Z
Br J Radiol; 2016; 89(1058):20150573. PubMed ID: 26642307
[TBL] [Abstract][Full Text] [Related]
35. Expression of TIGAR and its correlation with clinicopathology, prognosis, and 18F-FDG PET/CT parameters in patients with resectable pancreatic ductal adenocarcinoma.
Song Y; Wang PY; Zheng Y; Liu C; Wang XM
Nucl Med Commun; 2021 May; 42(5):528-534. PubMed ID: 33481504
[TBL] [Abstract][Full Text] [Related]
36. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.
Higashi T; Saga T; Nakamoto Y; Ishimori T; Mamede MH; Wada M; Doi R; Hosotani R; Imamura M; Konishi J
J Nucl Med; 2002 Feb; 43(2):173-80. PubMed ID: 11850481
[TBL] [Abstract][Full Text] [Related]
37. The relationship between HER2 expression and
Ozen A; Tatar G
Hell J Nucl Med; 2022; 25(1):5-10. PubMed ID: 35388798
[TBL] [Abstract][Full Text] [Related]
38. Utility of 18 fludeoxyglucose in preoperative positon-emission tomography-computed tomography (PET-CT) in the early diagnosis of exocrine pancreatic cancer: A study of 139 resected cases.
Sánchez-Bueno F; García-Pérez R; Claver Valderas MA; de la Peña Moral J; Frutos Esteban L; Ortiz Ruiz E; Fuster Quiñonero M; Parrilla Paricio P
Cir Esp; 2016 Nov; 94(9):511-517. PubMed ID: 27712835
[TBL] [Abstract][Full Text] [Related]
39. Relationship between the expression of PD-L1 and
Li J; Chen R; Chen Y; Xia Q; Zhou X; Xia Q; Wang C; Wan L; Bao H; Huang G; Liu J
Br J Cancer; 2023 Aug; 129(3):541-550. PubMed ID: 37311977
[TBL] [Abstract][Full Text] [Related]
40. Adenosquamous Carcinoma of the Pancreas Demonstrated on 18F-FDG PET/CT Imaging.
Jiang L; Nie H; Zhu L; Xiu Y; Shi H
Clin Nucl Med; 2017 Mar; 42(3):206-208. PubMed ID: 28098663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]